COHEN RAYMOND W 4

What Happened

• Raymond W. Cohen, a director of Kestra Medical Technologies, acquired 10,000 shares in an open-market purchase on March 26, 2026. The reported weighted-average price was $19.98 per share, for a total reported transaction value of $199,800. This was a purchase (insider buy), which investors often view as a stronger signal than routine sales.

Key Details

• Transaction date: 2026-03-26. Filing date: 2026-03-30 (see Form 4 for official timeliness status).
• Price: weighted average $19.98; footnote reports the execution prices ranged from $19.82 to $20.02.
• Shares acquired: 10,000; total reported cost: $199,800.
• Shares owned after transaction: Not specified in the information you provided (refer to the Form 4 for post-transaction holdings).
• Footnote: The filing notes the Column 4 price is a weighted average and offers to provide a breakdown of how many shares traded at each price within the $19.82–$20.02 range upon request.

Context

• Insider purchases are often watched by retail investors as a sign of confidence, though they do not prove future performance. This report reflects a straight purchase (code P) rather than an award, exercise, or gift. If you want the exact per-price breakdown or the insider’s holdings after the trade, consult the full Form 4 filing or contact the SEC staff or issuer as indicated in the footnote.